Angelini is characterized by its investment in research, development and marketing of products that meet the market needs, promoting the constant offer of opportunities for the pharmaceutical sector and people's well being. Angelini Portugal offer is wide and covers different needs in the area of treatment and prevention of diseases of the Central Nervous System (CNS) and Mental Disorders, Pain and inflammation, Oral Health and Food Supplements. Its wide experience in research dates back to the 1950's and has made Angelini products an international success, with the discovery of active ingredients that are still recognised by the market today, namely trazodone (antidepressant) and benzidamine (anti-inflammatory). The key to Angelini's success is to work side by side with doctors and pharmacists, through a group of qualified professionals, offering products with clear and differentiated positioning.